Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRI

Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRI

Background Prostate cancer recurrence is found in up to 40% of men with prior definitive (total prostatectomy or whole-prostate radiation) treatment. Prostate-specific membrane antigen PET agents such as 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine 3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Liza Lindenberg, Esther Mena, Barış Türkbey, Joanna H. Shih, Sarah E. Reese, Stephanie A. Harmon, Ilhan Lim, Frank I. Lin, Anita Ton, Yolanda McKinney, Philip Eclarinal, Deborah E. Citrin, William L. Dahut, Ravi A. Madan, Bradford J. Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Peter A. Pinto, Janet F. Eary, Peter L. Choyke
Médium: Artigo
Jazyk:angličtina
Vydáno: 2020
On-line přístup:https://doi.org/10.1148/radiol.2020192018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1148/radiol.2020192018

Podobné jednotky